$Gyre Therapeutics (GYRE.US)$
Feeling restless now.
Feeling restless now.
Translated
2
$Applied DNA Sciences (APDN.US)$
I was looking forward to it because it has been good here recently 😭
I was looking forward to it because it has been good here recently 😭
Translated
6
たかひと_1023
liked
$Applied DNA Sciences (APDN.US)$
Has the counterattack begun?
Has the counterattack begun?
Translated
5
$Gyre Therapeutics (GYRE.US)$
It's time to go up.
It's time to go up.
Translated
5
$Applied DNA Sciences (APDN.US)$
Please come about 300% higher🥹
Please come about 300% higher🥹
Translated
7
3
$Gyre Therapeutics (GYRE.US)$
Please drop to around 50 dollars soon!
I wonder if the materials will be available soon...
Please drop to around 50 dollars soon!
I wonder if the materials will be available soon...
Translated
12
$Gyre Therapeutics (GYRE.US)$
On November 22, 2024, at 4:15 p.m., the U.S. Securities and Exchange Commission (SEC) declared that the S-3 form of Gyre Therapeutics is effective. This is an important regulatory milestone for the company, allowing them to proceed with the planned offering of securities.
The effectiveness of the S-3 form is crucial for Gyre Therapeutics as it facilitates the company's fundraising ability through the sale of securities. This development is expected to enhance the company's financial flexibility and support strategic initiatives.
Investors should monitor the subsequent actions of Gyre Therapeutics after this regulatory approval as it could impact the company's financial position and market performance.
On November 22, 2024, at 4:15 p.m., the U.S. Securities and Exchange Commission (SEC) declared that the S-3 form of Gyre Therapeutics is effective. This is an important regulatory milestone for the company, allowing them to proceed with the planned offering of securities.
The effectiveness of the S-3 form is crucial for Gyre Therapeutics as it facilitates the company's fundraising ability through the sale of securities. This development is expected to enhance the company's financial flexibility and support strategic initiatives.
Investors should monitor the subsequent actions of Gyre Therapeutics after this regulatory approval as it could impact the company's financial position and market performance.
Translated
8
$Gyre Therapeutics (GYRE.US)$
I look forward to the exciting announcement.
It comes suddenly at that time.
I look forward to the exciting announcement.
It comes suddenly at that time.
Translated
12
たかひと_1023
liked and commented on
$Applied DNA Sciences (APDN.US)$
On 11/22, there is news of a second WHO smallpox emergency meeting regarding the ongoing smallpox epidemic in Africa on 11/12, gold.
On 11/16, news of Trump appointing an anti-vaccine person as the head of the Insurance and Welfare Department.
And, at this timing, news of the first infection in the usa...
It feels like something unsettling is in the air 💧
I also had doubts about the fact that there were no reported infections in the USA until now, but it was during the election period...
Go for it APDN 🚀
On 11/22, there is news of a second WHO smallpox emergency meeting regarding the ongoing smallpox epidemic in Africa on 11/12, gold.
On 11/16, news of Trump appointing an anti-vaccine person as the head of the Insurance and Welfare Department.
And, at this timing, news of the first infection in the usa...
It feels like something unsettling is in the air 💧
I also had doubts about the fact that there were no reported infections in the USA until now, but it was during the election period...
Go for it APDN 🚀
Translated
7
2
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)